Citigroup
ZBH icon

Citigroup’s Zimmer Biomet ZBH Stock Holding History

Citigroup’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,751
Closed -$262K – 7555
2020
Q4 		$262K Sell
1,751
-6,077
-78% -$858K ﹤0.01% 4778
2020
Q3 		$1.03M Buy
7,828
+4,738
+153% +$619K ﹤0.01% 3245
2020
Q2 		$358K Sell
3,090
-22,351
-88% -$2.58M ﹤0.01% 4556
2020
Q1 		$2.5M Sell
25,441
-9,579
-27% -$1.26M ﹤0.01% 2269
2019
Q4 		$5.09M Buy
35,020
+17,510
+100% +$2.42M ﹤0.01% 2016
2019
Q3 		$2.33M Buy
17,510
+8,446
+93% +$1.09M ﹤0.01% 2687
2019
Q2 		$1.04M Sell
9,064
-22,248
-71% -$2.61M ﹤0.01% 3580
2019
Q1 		$3.88M Buy
31,312
+2,987
+11% +$339K ﹤0.01% 2009
2018
Q4 		$2.85M Buy
28,325
+24,514
+643% +$2.76M ﹤0.01% 2332
2018
Q3 		$486K Sell
3,811
-13,184
-78% -$1.57M ﹤0.01% 4314
2018
Q2 		$1.84M Sell
16,995
-15,347
-47% -$1.67M ﹤0.01% 2747
2018
Q1 		$3.42M Sell
32,342
-10,197
-24% -$1.18M ﹤0.01% 2124
2017
Q4 		$4.98M Buy
42,539
+33,578
+375% +$3.8M ﹤0.01% 1838
2017
Q3 		$1.02M Buy
8,961
+206
+2% +$23.8K ﹤0.01% 3360
2017
Q2 		$1.09M Buy
8,755
+103
+1% +$12.2K ﹤0.01% 3217
2017
Q1 		$1.03M Sell
8,652
-13,287
-61% -$1.51M ﹤0.01% 3179
2016
Q4 		$2.2M Sell
21,939
-6,901
-24% -$740K ﹤0.01% 2829
2016
Q3 		$3.64M Buy
+28,840
New +$3.56M ﹤0.01% 1966
2016
Q2 		– Sell
-7,519
Closed -$778K – 7483
2016
Q1 		$778K Buy
+7,519
New +$727K ﹤0.01% 3634
2015
Q3 		– Sell
-25,132
Closed -$2.67M – 7757
2015
Q2 		$2.67M Buy
+25,132
New +$2.78M ﹤0.01% 2276
2014
Q1 		– Sell
-8,240
Closed -$746K – 7233
2013
Q4 		$746K Sell
8,240
-33,887
-80% -$2.93M ﹤0.01% 3458
2013
Q3 		$3.36M Sell
42,127
-19,776
-32% -$1.56M ﹤0.01% 2092
2013
Q2 		$4.5M Buy
+61,903
New +$4.63M ﹤0.01% 1730

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citigroup's ZBH Position: Q2 2026 in Review

Citigroup increased its Zimmer Biomet (ZBH) stake by 33% in Q2 2026, buying an estimated $5.66M and bringing the position to 258,982 shares worth $22.3M. The position accounts for 0.01% of the portfolio, ranked #1109.

Citigroup first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $76.6M in Q1 2021. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Citigroup held 258,982 shares of Zimmer Biomet worth $22.3M as of Q2 2026.
  • Citigroup bought 64,600 Zimmer Biomet shares in Q2 2026, an estimated $5.66M.
  • Zimmer Biomet made up 0.01% of Citigroup's portfolio in Q2 2026, its #1109 holding.
  • Citigroup first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Zimmer Biomet position peaked at $76.6M in Q1 2021.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.